BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32445400)

  • 1. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
    Nasiripour S; Zamani F; Farasatinasab M
    J Clin Pharmacol; 2020 Jul; 60(7):828-829. PubMed ID: 32445400
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
    Andreou A; Trantza S; Filippou D; Sipsas N; Tsiodras S
    In Vivo; 2020 Jun; 34(3 Suppl):1567-1588. PubMed ID: 32503814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

  • 4. Pros and cons of corticosteroid therapy for COVID-19 patients.
    Mattos-Silva P; Felix NS; Silva PL; Robba C; Battaglini D; Pelosi P; Rocco PRM; Cruz FF
    Respir Physiol Neurobiol; 2020 Sep; 280():103492. PubMed ID: 32659271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Costiniuk CT; Jenabian MA
    Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
    [No Abstract]   [Full Text] [Related]  

  • 6. The Multiple Effects of SGLT2 Inhibitors Suggest Potential Benefit in COVID-19 Patients.
    Soni S; Dyck JRB
    Can J Cardiol; 2020 Oct; 36(10):1691.e3. PubMed ID: 32717278
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful use of methylprednisolone for treating severe COVID-19.
    Liu J; Zheng X; Huang Y; Shan H; Huang J
    J Allergy Clin Immunol; 2020 Aug; 146(2):325-327. PubMed ID: 32479759
    [No Abstract]   [Full Text] [Related]  

  • 8. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?
    Deftereos S; Giannopoulos G; Vrachatis DA; Siasos G; Giotaki SG; Cleman M; Dangas G; Stefanadis C
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):255. PubMed ID: 32337546
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis.
    Elshafei MN; Khalil A; El-Bardissy A; Danjuma M; Ahmed MB; Mohamed MFH
    Medicine (Baltimore); 2020 Sep; 99(36):e21911. PubMed ID: 32899023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
    Imazio M; Brucato A; Lazaros G; Andreis A; Scarsi M; Klein A; De Ferrari GM; Adler Y
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):625-629. PubMed ID: 32658005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we unstress SARS-CoV-2 infected cells?
    Csukasi F; Rico G; Becerra J; Duran I
    Cytokine Growth Factor Rev; 2020 Aug; 54():3-5. PubMed ID: 32563554
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential role of statins in COVID-19.
    Lee KCH; Sewa DW; Phua GC
    Int J Infect Dis; 2020 Jul; 96():615-617. PubMed ID: 32502659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients.
    Parikh R; Wilson C; Weinberg J; Gavin D; Murphy J; Reardon CC
    Ther Adv Respir Dis; 2020; 14():1753466620933510. PubMed ID: 32539647
    [No Abstract]   [Full Text] [Related]  

  • 14. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
    Demidowich AP; Levine JA; Apps R; Cheung FK; Chen J; Fantoni G; ; Patel TP; Yanovski JA
    Int J Obes (Lond); 2020 Aug; 44(8):1793-1799. PubMed ID: 32461554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?
    Abobaker A
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1619-1620. PubMed ID: 32607779
    [No Abstract]   [Full Text] [Related]  

  • 16. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
    Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine may not be effective in COVID-19 infection; it may even be harmful?
    Cumhur Cure M; Kucuk A; Cure E
    Clin Rheumatol; 2020 Jul; 39(7):2101-2102. PubMed ID: 32394215
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 and Hypercoagulable State: A New Therapeutic Perspective.
    Nascimento JHP; Gomes BFO; Carmo JĂșnior PRD; Petriz JLF; Rizk SI; Costa IBSDS; Lacerda MVG; Bacal F; Hajjar LA; Oliveira GMM
    Arq Bras Cardiol; 2020 Jun; 114(5):829-833. PubMed ID: 32491074
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical Toxicology and COVID-19: Our Role in a Pandemic.
    Neumann NR; Chai PR; Wood DM; Greller HA; Mycyk MB
    J Med Toxicol; 2020 Jul; 16(3):245-247. PubMed ID: 32356251
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 Infection in a 2-Week-Old Male With Neutropenia.
    Patek P; Corcoran J; Adams L; Khandhar P
    Clin Pediatr (Phila); 2020 Sep; 59(9-10):918-920. PubMed ID: 32292054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.